Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

about

Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation

P2860

Q42635215-93F4E6D4-76CB-418E-8B0B-099A873246EA

P2860

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

Item

http://www.wikidata.org/entity/Q35776206

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

@ast

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

@en

type

Item

label

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

@ast

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

@en

prefLabel

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

@ast

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

@en

P1476

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

@en

P2093

Zeev Blumenfeld

http://www.w3.org/2001/XMLSchema#string

P2860

Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey

GnRH-agonists in fertility preservation.

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist treatment

Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients

How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.

GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.

P304

162-163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2011-0351

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221802968

http://www.w3.org/2001/XMLSchema#string

P698

22302230

http://www.w3.org/2001/XMLSchema#string

P932

3286163

http://www.w3.org/2001/XMLSchema#string

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

about

P2860

P2860

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932